Literature DB >> 27064263

Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients.

Pratima Sharma1, Neehar D Parikh1,2, Jessica Yu3, Pranab Barman4, Brian A Derstine5, Christopher J Sonnenday6, Stewart C Wang6,5, Grace L Su1,5,2.   

Abstract

Hepatocellular carcinoma (HCC) is a common indication for liver transplantation (LT). Recent data suggest that body composition features strongly affect post-LT mortality. We examined the impact of body composition on post-LT mortality in patients with HCC. Data on adult LT recipients who received Model for End-Stage Liver Disease exception for HCC between February 29, 2002, and December 31, 2013, and who had a computed tomography (CT) scan any time 6 months prior to LT were reviewed (n = 118). All available CT scan Digital Imaging and Communication in Medicine files were analyzed using a semiautomated high throughput methodology with algorithms programmed in MATLAB. Analytic morphomics measurements including dorsal muscle group (DMG) area, visceral and subcutaneous fat, and bone mineral density (BMD) were taken at the bottom of the eleventh thoracic vertebral level. Thirty-two (27%) patients died during the median follow-up of 4.4 years. The number of HCC lesions (hazard ratio [HR], 2.81; P < 0.001), BMD (HR = 0.90/Hounsfield units [HU]; P = 0.03), pre-LT locoregional therapy (HR = 0.14; P < 0.001), and donor age (HR = 1.05; P < 0.001) were the independent predictors of post-LT mortality. DMG area did not affect post-LT survival. In conclusion, in addition to number of HCC lesions and pre-LT locoregional therapy, low BMD, a surrogate for bone loss rather than DMG area, was independently associated with post-LT mortality in HCC patients. Bone loss may be an early marker of deconditioning that precedes sarcopenia and may affect transplant outcomes. Liver Transplantation 22 1092-1098 2016 AASLD.
© 2016 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2016        PMID: 27064263      PMCID: PMC4961525          DOI: 10.1002/lt.24458

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  31 in total

1.  Visceral adiposity is negatively associated with bone density and muscle attenuation.

Authors:  Peng Zhang; Mark Peterson; Grace L Su; Stewart C Wang
Journal:  Am J Clin Nutr       Date:  2014-11-26       Impact factor: 7.045

2.  One-year postoperative resource utilization in sarcopenic patients.

Authors:  Peter S Kirk; Jeffrey F Friedman; David C Cron; Michael N Terjimanian; Stewart C Wang; Darrell A Campbell; Michael J Englesbe; Nicole L Werner
Journal:  J Surg Res       Date:  2015-04-30       Impact factor: 2.192

3.  Use of analytic morphomics of liver, spleen, and body composition to identify patients at risk for cirrhosis.

Authors:  Venkat Krishnamurthy; Peng Zhang; Sampath Ethiraj; Binu Enchakalody; Akbar K Waljee; Lu Wang; Stewart C Wang; Grace L Su
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-30       Impact factor: 11.382

4.  Osteosarcopenic obesity is associated with reduced handgrip strength, walking abilities, and balance in postmenopausal women.

Authors:  J Z Ilich; J E Inglis; O J Kelly; D L McGee
Journal:  Osteoporos Int       Date:  2015-05-30       Impact factor: 4.507

5.  Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications.

Authors:  Perry J Pickhardt; B Dustin Pooler; Travis Lauder; Alejandro Muñoz del Rio; Richard J Bruce; Neil Binkley
Journal:  Ann Intern Med       Date:  2013-04-16       Impact factor: 25.391

6.  Liver transplantation for hepatocellular carcinoma: the MELD impact.

Authors:  Pratima Sharma; Vijayan Balan; Jose L Hernandez; Ann M Harper; Erick B Edwards; Hector Rodriguez-Luna; Thomas Byrne; Hugo E Vargas; David Mulligan; Jorge Rakela; Russell H Wiesner
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

Review 7.  Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation.

Authors:  Srinivasan Dasarathy
Journal:  Dig Dis Sci       Date:  2013-08-04       Impact factor: 3.199

8.  Survival benefit-based deceased-donor liver allocation.

Authors:  D E Schaubel; M K Guidinger; S W Biggins; J D Kalbfleisch; E A Pomfret; P Sharma; R M Merion
Journal:  Am J Transplant       Date:  2009-04       Impact factor: 8.086

9.  Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.

Authors:  Judith Meza-Junco; Aldo J Montano-Loza; Vickie E Baracos; Carla M M Prado; Vincent G Bain; Crystal Beaumont; Nina Esfandiari; Jessica R Lieffers; Michael B Sawyer
Journal:  J Clin Gastroenterol       Date:  2013 Nov-Dec       Impact factor: 3.062

10.  Analytic morphomics, core muscle size, and surgical outcomes.

Authors:  Michael J Englesbe; Jay S Lee; Kevin He; Ludi Fan; Douglas E Schaubel; Kyle H Sheetz; Calista M Harbaugh; Sven A Holcombe; Darrel A Campbell; Christopher J Sonnenday; Stewart C Wang
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

View more
  18 in total

1.  Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma.

Authors:  Yosuke Miyachi; Toshimi Kaido; Siuan Yao; Hisaya Shirai; Atsushi Kobayashi; Yuhei Hamaguchi; Naoko Kamo; Shintaro Yagi; Shinji Uemoto
Journal:  World J Surg       Date:  2019-03       Impact factor: 3.352

2.  Impact of osteopenia and neutropenia in patients with colorectal cancer treated with FOLFOXIRI: a retrospective cohort study.

Authors:  Toshihiro Nakao; Mitsuo Shimada; Kozo Yoshikawa; Takuya Tokunaga; Masaaki Nishi; Hideya Kashihara; Chie Takasu; Yuma Wada; Toshiaki Yoshimoto; Syoko Yamashita
Journal:  Int J Clin Oncol       Date:  2022-07-30       Impact factor: 3.850

3.  Significance of osteopenia in elderly patients undergoing emergency gastrointestinal surgery.

Authors:  Yasuhiro Takano; Shu Tsukihara; Wataru Kai; Daisuke Ito; Hironori Kanno; Kyonsu Son; Nobuyoshi Hanyu; Ken Eto
Journal:  Ann Gastroenterol Surg       Date:  2022-02-12

4.  Impact of Osteopenia on Oncologic Outcomes After Curative Resection for Pancreatic Cancer.

Authors:  Takashi Motomura; Hideaki Uchiyama; Tomohiro Iguchi; Mizuki Ninomiya; Rintaro Yoshida; Takuya Honboh; Noriaki Sadanaga; Tetsuro Akashi; Hiroshi Matsuura
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

5.  Prognostic Impact of Osteopenia in Patients Who Underwent Living Donor Liver Transplantation for Hepatocellular Carcinoma.

Authors:  Takeo Toshima; Tomoharu Yoshizumi; Yukiko Kosai-Fujimoto; Shoichi Inokuchi; Shohei Yoshiya; Kazuki Takeishi; Shinji Itoh; Noboru Harada; Toru Ikegami; Yuji Soejima; Masaki Mori
Journal:  World J Surg       Date:  2020-01       Impact factor: 3.352

6.  Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.

Authors:  Neehar D Parikh; Peng Zhang; Amit G Singal; Brian A Derstine; Venkat Krishnamurthy; Pranab Barman; Akbar K Waljee; Grace L Su
Journal:  Cancer Res Treat       Date:  2017-06-01       Impact factor: 4.679

7.  Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study.

Authors:  Elliot B Tapper; Peng Zhang; Rohan Garg; Tori Nault; Kate Leary; Venkat Krishnamurthy; Grace L Su
Journal:  JHEP Rep       Date:  2019-12-05

8.  Computed tomography-measured bone mineral density as a surrogate marker of survival after resection of colorectal liver metastases.

Authors:  Shinichi Ikuta; Tsukasa Aihara; Takayoshi Nakajima; Meidai Kasai; Naoki Yamanaka
Journal:  Ann Transl Med       Date:  2021-01

9.  Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.

Authors:  Young Ri Kim; Sukhee Park; Sangbin Han; Joong Hyun Ahn; Seonwoo Kim; Dong Hyun Sinn; Woo Kyoung Jeong; Justin S Ko; Mi Sook Gwak; Gaab Soo Kim
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

10.  Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.

Authors:  Kung-Hao Liang; Peng Zhang; Chih-Lang Lin; Stewart C Wang; Tsung-Hui Hu; Chau-Ting Yeh; Grace L Su
Journal:  Dig Dis Sci       Date:  2019-11-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.